AGF Management Ltd Lowers Holdings in Apellis Pharmaceuticals, Inc (NASDAQ:APLS) tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright reaffirmed their buy rating on shares of Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) in a report released on Friday, Benzinga reports. The firm currently has a $92.00 target price on the stock. Other equities research analysts have also recently issued research reports about the company. UBS Group upped their target price on Apellis […]
Analysts Set Apellis Pharmaceuticals, Inc (NASDAQ:APLS) Target Price at $78 60 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Point72 Asset Management L.P. trimmed its stake in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 34.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,239,361 shares of the company’s stock after selling 640,363 shares during the period. Point72 Asset Management […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) was the recipient of a large increase in short interest in the month of September. As of September 30th, there was short interest totalling 16,770,000 shares, an increase of 23.2% from the September 15th total of 13,610,000 shares. Based on an average daily volume of 5,100,000 shares, […]